105 results
Page 4 of 6
SC TO-T
EX-99
jwyqz6e7
13 Jan 12
Third party tender offer statement
12:00am
8-K
EX-99.1
383dmrba65zjg5hs
27 Oct 11
Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development
12:00am
8-K
EX-99.1
wo8474
28 Jul 11
Important Clinical Data and Strong Financial Results
12:00am
8-K
EX-99.1
bywaydnuvl sbtt46r
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
u158syg6 s6ght6
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-99.1
aaiysh 2tdmnewah149
26 Oct 10
Robust Clinical Data and the Strategic Acquisition of ZymoGenetics
12:00am
8-K
EX-99.1
5u2i0l8e965iswx
22 Jul 10
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data
12:00am
8-K
EX-99.1
qqar 0rx5ncv
29 Apr 10
Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter
12:00am
8-K
EX-99.1
aw1ism5d8k7xve
28 Jan 10
Strong Operational and Strategic Performance in Fourth Quarter Caps Transformative 2009
12:00am